References
Key articles
European Association of Urology. EAU guidelines on urological trauma. Mar 2025 [internet publication].Full text
American Urological Association. Urotrauma (2020). Apr 2020 [internet publication].Full text
Nielsen M, Qaseem A. Hematuria as a marker of occult urinary tract cancer: advice for high-value care from the American College of Physicians. Ann Intern Med. 2016 Apr 5;164(7):488-97.Full text Abstract
American College of Radiology. ACR appropriateness criteria: hematuria. 2019 [internet publication].Full text
Reference articles
1. Takeuchi M, McDonald JS, Takahashi N, et al. Cancer prevalence and risk stratification in adults presenting with hematuria: a population-based cohort study. Mayo Clin Proc Innov Qual Outcomes. 2021 Apr;5(2):308-19.Full text Abstract
2. Rai BP, Luis Dominguez Escrig J, Vale L, et al. Systematic review of the incidence of and risk factors for urothelial cancers and renal cell carcinoma among patients with haematuria. Eur Urol. 2022 Aug;82(2):182-92. Abstract
3. Edwards TJ, Dickinson AJ, Natale S, et al. A prospective analysis of the diagnostic yield resulting from 4020 patients at a protocol-driven haematuria clinic. BJU Int. 2006 Feb;97(2):301-5. Abstract
4. Buntinx F, Wauters H. The diagnostic value of macroscopic haematuria in diagnosing urological cancers: a meta-analysis. Fam Pract. 1997 Feb;14(1):63-8.Full text Abstract
5. Bruyninckx R, Buntinx F, Aertgeerts B, et al. The diagnostic value of macroscopic haematuria for the diagnosis of urological cancer in general practice. Br J Gen Pract. 2003 Jan;53(486):31-5.Full text Abstract
6. Lucca I, Klatte T, Fajkovic H, et al. Gender differences in incidence and outcomes of urothelial and kidney cancer. Nat Rev Urol. 2015 Oct;12(10):585-92. Abstract
7. Jubber I, Ong S, Bukavina L, et al. Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur Urol. 2023 Aug;84(2):176-90.Full text Abstract
8. Kabaria R, Klaassen Z, Terris MK. Renal cell carcinoma: links and risks. Int J Nephrol Renovasc Dis. 2016;9:45-52.Full text Abstract
9. Dy GW, Gore JL, Forouzanfar MH, et al. Global burden of urologic cancers, 1990-2013. Eur Urol. 2017 Mar;71(3):437-46. Abstract
10. National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. Jan 2026 [internet publication].Full text
11. Barnes H, Holland AE, Westall GP, et al. Cyclophosphamide for connective tissue disease-associated interstitial lung disease. Cochrane Database Syst Rev. 2018 Jan 3;(1):CD010908.Full text Abstract
12. Mukhtar S, Woodhouse C. The management of cyclophosphamide-induced haematuria. BJU Int. 2010 Apr;105(7):908-12. Abstract
13. Powles T, Bellmunt J, Comperat E, et al. Bladder cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022 Mar;33(3):244-58.Full text Abstract
14. Rouprêt M, Babjuk M, Compérat E, et al. European Association of Urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 Update. Eur Urol. 2015 Nov;68(5):868-79. Abstract
15. Hicks D, Li CY. Management of macroscopic haematuria in the emergency department. Postgrad Med J. 2008 Oct;84(996):539-44. Abstract
16. Hansen RS, Biørn SH, Birk-Korch JB, et al. Prevalence of prostate cancer in men with haematuria: a systematic review and meta-analysis. BJU Int. 2023 May;131(5):530-9.Full text Abstract
17. European Association of Urology. EAU guidelines on urological trauma. Mar 2025 [internet publication].Full text
18. Tanagho EA, McAninch JW. Smith's general urology, 16th ed. New York, NY: McGraw-Hill; 2003.
19. Voelzke BB, Leddy L. The epidemiology of renal trauma. Transl Androl Urol. 2014 Jun;3(2):143-9.Full text Abstract
20. American Urological Association. Urotrauma (2020). Apr 2020 [internet publication].Full text
21. Avey G, Blackmore CC, Wessells H, et al. Radiographic and clinical predictors of bladder rupture in blunt trauma patients with pelvic fracture. Acad Radiol. 2006 May;13(5):573-9. Abstract
22. Velazquez N, Fantus RJ, Fantus RJ, et al. Blunt trauma pelvic fracture-associated genitourinary and concomitant lower gastrointestinal injury: incidence, morbidity, and mortality. World J Urol. 2020 Jan;38(1):231-8. Abstract
23. Minotti B, Treglia G, Pascale M, et al. Prevalence of microhematuria in renal colic and urolithiasis: a systematic review and meta-analysis. BMC Urol. 2020 Aug 8;20(1):119.Full text Abstract
24. Macey MR, Raynor MC. Medical and surgical treatment modalities for lower urinary tract symptoms in the male patient secondary to benign prostatic hyperplasia: a review. Semin Intervent Radiol. 2016 Sep;33(3):217-23.Full text Abstract
25. Foley SJ, Soloman LZ, Wedderburn AW, et al. A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride. J Urol. 2000 Feb;163(2):496-8. Abstract
26. Nyman MA, Schwenk NM, Silverstein MD. Management of urinary retention: rapid versus gradual decompression and risk of complications. Mayo Clin Proc. 1997 Oct;72(10):951-6. Abstract
27. Wu MY, Chang JR, Lee YK, et al. The effect and safety of rapid and gradual urinary decompression in urine retention: a systematic review and meta-analysis. Medicina (Kaunas). 2022 Oct 13;58(10):1441.Full text Abstract
28. Subiela JD, Balla A, Bollo J, et al. Endovascular management of ureteroarterial fistula: single institution experience and systematic literature review. Vasc Endovascular Surg. 2018 Feb 26;52(4):275-86. Abstract
29. Jiang S, Wang Y, Zhang Z, et al. Accuracy of hematuria for predicting non-diabetic renal disease in patients with diabetes and kidney disease: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2018 Sep;143:288-300. Abstract
30. De Costa C, McLaughlin K, Noseworthy TW. Criteria for referring patients with renal disease for nephrology consultation: a review of the literature. J Nephrol. 2010 Jul-Aug;23(4):399-407. Abstract
31. Le Joncour A, Mesnard L, Hertig A, et al. Red urine, updated for the nephrologist: a case report. BMC Nephrol. 2018 Jun 8;19(1):133.Full text Abstract
32. Bhatt NR, Davis NF, Nolan WJ, et al. Incidence of visible hematuria among antithrombotic agents: a systematic review of over 175,000 patients. Urology. 2018 Apr;114:27-32. Abstract
33. Alamdarloo SM, Hashemi A, Hessami K, et al. Gross hematuria and placenta percreta: report of two cases and literature review. J Obstet Gynaecol Res. 2025 Jan;51(1):e16177. Abstract
34. Balan R, Radu VD, Giușcă SE, et al. A rare cause of massive hematuria: placenta percreta with bladder invasion. In Vivo. 2021 Nov-Dec;35(6):3633-9.Full text Abstract
35. Jauniaux E, Grønbeck L, Bunce C, et al. Epidemiology of placenta previa accreta: a systematic review and meta-analysis. BMJ Open. 2019 Nov 12;9(11):e031193.Full text Abstract
36. Chorbińska J, Krajewski W, Zdrojowy R. Urological complications after radiation therapy-nothing ventured, nothing gained: a narrative review. Transl Cancer Res. 2021 Feb;10(2):1096-118.Full text Abstract
37. Leapman MS, Hall SJ, Stone NN, et al. Haematuria after prostate brachytherapy. BJU Int. 2013 Jan 29;111(8):E319-24.Full text Abstract
38. Sivakumaran P, Barros B, Antonio Dias VL, et al. A retrospective cohort study of monthly rifampicin, ofloxacin and minocycline in the management of leprosy at the hospital for tropical diseases, London, United Kingdom. PLoS Negl Trop Dis. 2024 Dec;18(12):e0012699.Full text Abstract
39. Reichmann H. Real-world considerations regarding the use of the combination of levodopa, carbidopa, and entacapone (Stalevo(®) ) in Parkinson's disease. Eur J Neurol. 2023 Nov;30 Suppl 2:15-20.Full text Abstract
40. Moharamzadeh P, Ojaghihaghighi S, Amjadi M, et al. Effect of tranexamic acid on gross hematuria: a pilot randomized clinical trial study. Am J Emerg Med. 2017 Sep 9;35(12):1922-5. Abstract
41. O'Connor E, McVey A, Demkiw S, et al. Assessment and management of haematuria in the general practice setting. Aust J Gen Pract. 2021 Jul;50(7):467-71.Full text Abstract
42. Mariani AJ. The evaluation of adult hematuria: a clinical update. In: AUA update series 1998; volume XVII, lesson 24. Houston, TX: AUA Office of Education; 1998:185-92.
43. Nielsen M, Qaseem A. Hematuria as a marker of occult urinary tract cancer: advice for high-value care from the American College of Physicians. Ann Intern Med. 2016 Apr 5;164(7):488-97.Full text Abstract
44. Moloney F, Murphy KP, Twomey M, et al. Haematuria: an imaging guide. Adv Urol. 2014;2014:414125.Full text Abstract
45. Ingelfinger JR. Hematuria in Adults. N Engl J Med. 2021 Jul 8;385(2):153-163. Abstract
46. Luciano RL, Perazella MA. Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment. Drug Saf. 2015 Jan;38(1):55-64.Full text Abstract
47. Sing RI, Singal RK. What is significant hematuria for the primary care physician? Can J Urol. 2012 Oct;19(suppl 1):36-41.Full text Abstract
48. American College of Radiology. ACR appropriateness criteria: pretreatment staging of urothelial cancer. 2024 [internet publication].Full text
49. Centers for Disease Control and Prevention. Group a strep infection: clinical guidelines for post-streptococcal glomerulonephritis. Mar 2024 [internet publication].Full text
50. Tasian GE, Jemielita T, Goldfarb DS, et al. Oral antibiotic exposure and kidney stone disease. J Am Soc Nephrol. 2018 May 10;29(6):1731-40. Abstract
51. Wei JT, Barocas D, Carlsson S, et al. Early detection of prostate cancer: AUA/SUO guideline part I: prostate cancer screening. J Urol. 2023 Jul;210(1):46-53.Full text Abstract
52. Aneese AM, Manuballa V, Amin M, et al. Bladder urothelial carcinoma extending to rectal mucosa and presenting with rectal bleeding. World J Gastrointest Endosc. 2017 Jun 16;9(6):282-95.Full text Abstract
53. Barocas DA, Lotan Y, Matulewicz RS, et al. Updates to microhematuria: AUA/SUFU guideline (2025). J Urol. 2025 May;213(5):547-57.Full text Abstract
54. American College of Radiology. ACR appropriateness criteria: hematuria. 2019 [internet publication].Full text
55. National Institute for Health and Care Excellence. Renal and ureteric stones: assessment and management. Jan 2019 [internet publication].Full text
56. Kravchick S, Cherniavsky E, Verchovsky G, et al. Multidetector computed tomographic urography (MDCTU): its practical role in diagnosis of upper tract urothelial cancer in patients 50 years and older with different types of hematuria. Pathol Oncol Res. 2019 Jan;25(1):249-54. Abstract
57. Chlapoutakis K, Theocharopoulos N, Yarmenitis S, et al. Performance of computed tomographic urography in diagnosis of upper urinary tract urothelial carcinoma, in patients presenting with hematuria: systematic review and meta-analysis. Eur J Radiol. 2010 Feb;73(2):334-8. Abstract
58. Wang LJ, Wong YC, Huang CC, et al. Multidetector computerized tomography urography is more accurate than excretory urography for diagnosing transitional cell carcinoma of the upper urinary tract in adults with hematuria. J Urol. 2010 Jan;183(1):48-55. Abstract
59. Van Der Molen AJ, Cowan NC, Mueller-Lisse UG, et al; CT Urography Working Group of the European Society of Urogenital Radiology (ESUR). CT urography: definition, indications and techniques: a guideline for clinical practice. Eur Radiol. 2008 Jan;18(1):4-17. Abstract
60. Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006 Apr;(100):S11-5. Abstract
61. American College of Radiology. ACR appropriateness criteria: hematuria - child. 2018 [internet publication].Full text
62. Paner GP, Zehnder P, Amin AM, et al. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management. Adv Anat Pathol. 2011 Jan;18(1):79-89. Abstract
63. Silverman SG, Leyendecker JR, Amis ES Jr. What is the current role of CT urography and MR urography in the evaluation of the urinary tract? Radiology. 2009 Feb;250(2):309-23.Full text Abstract
64. Yecies T, Bandari J, Macleod L, et al. Evaluation of the Risks and Benefits of Computed Tomography Urography for Assessment of Gross Hematuria. Urology. 2019 Nov;133:40-45.Full text Abstract
65. American College of Radiology. ACR appropriateness criteria: acute onset flank pain-suspicion of stone disease (Urolithiasis). 2023 [internet publication].Full text
66. Sourtzis S, Thibeau JF, Damry N, et al. Radiologic investigation of renal colic: unenhanced helical CT compared with excretory urography. AJR Am J Roentgenol. 1999 Jun;172(6):1491-4. Abstract
67. Eisner BH, McQuaid JW, Hyams E, et al. Nephrolithiasis: what surgeons need to know. AJR Am J Roentgenol. 2011 Jun;196(6):1274-8.Full text Abstract
68. Willis SR, Ahmed HU, Moore CM, et al. Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysis. BMJ Open. 2014 Jun 15;4(6):e004895.Full text Abstract
69. Drost FH, Osses DF, Nieboer D, et al. Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. Cochrane Database Syst Rev. 2019 Apr 25;(4):CD012663.Full text Abstract
70. Powles T, Albiges L, Bex A, et al. Renal cell carcinoma: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024 Aug;35(8):692-706.Full text Abstract
71. Simundic AM, Bölenius K, Cadamuro J, et al. Joint EFLM-COLABIOCLI recommendation for venous blood sampling. Clin Chem Lab Med 2018;56(12):2015-38. Abstract
72. Little P, Turner S, Rumsby K, et al. Validating the prediction of lower urinary tract infection in primary care: sensitivity and specificity of urinary dipsticks and clinical scores in women. Br J Gen Pract. 2010 Jul;60(576):495-500.Full text Abstract
73. Pappas PG. Laboratory in the diagnosis and management of urinary tract infections. Med Clin North Am. 1991 Mar;75(2):313-25. Abstract
74. European Association of Urology. Non-muscle-invasive bladder cancer. Mar 2025 [internet publication].Full text
75. American Cancer Society. Screening tests for prostate cancer. Nov 2023 [internet publication].Full text
76. Harada T, Abe T, Kato F, et al. Five-point Likert scaling on MRI predicts clinically significant prostate carcinoma. BMC Urol. 2015 Sep 4;15:91.Full text Abstract
77. National Institute for Health and Care Excellence. Prostate cancer: diagnosis and management. Dec 2021 [internet publication].Full text
78. European Association of Urology. Urological trauma. Mar 2025 [internet publication].Full text
79. The American Association for the Surgery of Trauma. Injury scoring scale; a resource for trauma care professionals. [internet publication].Full text
80. Morey AF, McAninch JW, Tiller BK, et al. Single shot intraoperative excretory urography for the immediate evaluation of renal trauma. J Urol. 1999 Apr;161(4):1088-92. Abstract
81. Yeung LL, McDonald AA, Como JJ, et al. Management of blunt force bladder injuries: a practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2019 Feb;86(2):326-36.Full text Abstract
82. American College of Radiology. ACR appropriateness criteria: penetrating trauma – lower abdomen and pelvis. 2019 [internet publication].Full text
83. James PD, Connell NT, Ameer B, et al. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv. 2021 Jan 12;5(1):280-300.Full text Abstract
84. Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017 Jan 15;64(2):111-5.Full text Abstract
85. Nataraj G, Kurup S, Pandit A, et al. Correlation of fine needle aspiration cytology, smear and culture in tuberculous lymphadenitis: a prospective study. J Postgrad Med. 2002 Apr-Jun;48(2):113-6.Full text Abstract
86. Muneer A, Macrae B, Krishnamoorthy S, et al. Urogenital tuberculosis - epidemiology, pathogenesis and clinical features. Nat Rev Urol. 2019 Oct;16(10):573-98.Full text Abstract
87. Geldmacher H, Taube C, Kroeger C, et al. Assessment of lymph node tuberculosis in northern Germany: a clinical review. Chest. 2002 Apr;121(4):1177-82. Abstract
88. Weir MR, Thornton GF. Extrapulmonary tuberculosis. Experience of a community hospital and review of the literature. Am J Med. 1985 Oct;79(4):467-78. Abstract
89. Baydur A. The spectrum of extrapulmonary tuberculosis. West J Med. 1977 Apr;126(4):253-62.Full text Abstract
90. World Health Organization. WHO consolidated guidelines on tuberculosis: module 3: diagnosis. Apr 2025 [internet publication].Full text
91. Centers for Disease Control and Prevention (CDC). Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep. 2009 Jan 16;58(1):7-10.Full text Abstract
92. Bjerrum S, Schiller I, Dendukuri N, et al. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV. Cochrane Database Syst Rev. 2019 Oct 21;10(10):CD011420.Full text Abstract
93. Warshauer DM, McCarthy SM, Street L, et al. Detection of renal masses: sensitivities and specificities of excretory urography/linear tomography, US, and CT. Radiology. 1988 Nov;169(2):363-5. Abstract
94. Dong XQ, Shen Y, Xu LW, et al. Contrast-enhanced ultrasound for detection and diagnosis of renal clear cell carcinoma. Chin Med J (Engl). 2009 May 20;122(10):1179-83. Abstract
95. Heidenreich A, Ravery V; European Society of Oncological Urology. Preoperative imaging in renal cell cancer. World J Urol. 2004 Nov;22(5):307-15. Abstract
96. American Urological Association. Renal mass and localized renal cancer: evaluation, management, and follow up (2021). Jan 2021 [internet publication].Full text Abstract
97. Silverman SG, Israel GM, Herts BR, et al. Management of the incidental renal mass. Radiology. 2008 Oct;249(1):16-31. Abstract
Use of this content is subject to our disclaimer